TrademarkDir
CYTOSORB THERAPEUTIC ECMO
LIVE

Serial Number

98689487

Owner

CYTOSORBENTS CORPORATION

Attorney

Kevin M. Bovard

Filing Date

Aug 8, 2024

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

CYTOSORB THERAPEUTIC ECMO Trademark

Serial Number: 98689487

CYTOSORB THERAPEUTIC ECMO is a trademark filed by CYTOSORBENTS CORPORATION on August 8, 2024. The trademark is classified under Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

CYTOSORBENTS CORPORATION (35 trademarks)

Suite K
Monmouth Junction, NJ 08852

Entity Type: 03

Trademark Details

Filing Date

August 8, 2024

Registration Date

Not Registered

Published for Opposition

March 25, 2025

Goods & Services

Medical devices, namely, absorption devices and polymeric absorption materials for removing material from blood and blood fractions for use during extra corporeal membrane oxygenation

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 25, 2026 EXRA
SOU EXTENSION 2 GRANTED
Feb 24, 2026 EX2G
SOU EXTENSION 2 FILED
Feb 24, 2026 EXT2
SOU TEAS EXTENSION RECEIVED
Feb 24, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 13, 2025 EXRA
SOU EXTENSION 1 GRANTED
Nov 12, 2025 EX1G
SOU EXTENSION 1 FILED
Nov 12, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 12, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 20, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 25, 2025 NPUB
PUBLISHED FOR OPPOSITION
Mar 25, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 19, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 27, 2025 CNSA
ASSIGNED TO EXAMINER
Feb 14, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 16, 2025 NWOS
NEW APPLICATION ENTERED
Aug 8, 2024 NWAP

Related Trademarks

More from this Owner

PURIFI

PURIFI

PURIFI

PURIFI

ENTERICA

ENTERICA

HEMODEFEND

HEMODEFEND

HEMODEFEND

HEMODEFEND

CYTOSORB THERAPY REGAIN CONTROL

CYTOSORB THERAPY REGAIN CONTROL